低分子肝素治疗胎儿生长受限的护理干预-论文.pdf

《低分子肝素治疗胎儿生长受限的护理干预-论文.pdf》由会员上传分享，免费在线阅读，更多相关内容在应用文档-天天文库。

1、·I临床护理·中国现代医生2014年5月第52卷第15期低分子肝素治疗胎儿生长受限的护理干预黄捷吴华璋陈若子潘姜芬彭澎陈锡朗1．浙江省平阳县人民医院产科，浙江平阳325400；2．浙江省人民医院妇产科，浙江杭州310014【摘要】目的探讨低分子肝素治疗胎儿生长受限的临床效果以及护理措施。方法选择我院2010年3月~2012年3月间出现胎儿生长受限的72例妊娠妇女，患者入院后皮下注射5000U／d低分子肝素治疗，并选取我院同期胎儿生长受限的72例妊娠妇女接受基础治疗作为对照组。结果实验组治疗后平均宫高增量及胎儿股骨长、头围、腹围增量均显著高于对照组；实验组胎龄(

2、38~3)周，对照组(37~3)周；实验组出生体重(2750~378)g，对照组(2240~330)g；实验组胎盘质量(490~1lO)g，对照组(415~100)g。实验组并发症发生率明显低于对照组，上述比较项差异显著(P<0．05)。结论在进行治疗时要加强医患沟通，用药过程中密切观察患者表现、有无不良反应出现，早期进行健康教育，从而提高治疗效果。【关键词】低分子肝素；胎儿生长受限；护理干预【中图分类号】R473．72[文献标识码】B【文章编号]1673—9701(2014)15-0102-03Lowmolecularweightheparininthetr

3、eatmentoffetalgrowthrestrictionandnursinginterventionHUANGJieWUHuazhanfCHENRuozilPANJiarg~enPENGPenCHENXilanf1．DepartmentofGynecologyandObstetrics，PeopleSHospitalofPingyanginZhejiangProvince，Pingyang325400，China；2．DepartmentofGynecologyandObstetrics，ZhejiangProvincePeopleSHospital，H

4、angzhou310014，China【Abstract】0bjectiveTostudytheclinicaleffectsofLowmolecularweightheparininthetreatmentoffetalgrowthre·strictionandrelatednursinginterventions．MethodsChoose72pregnantwomenwithfetalgrowthrestrictioninourhos—pitalfromMarch2010toMarch2012，theyweretreatedwithsubcutaneou

5、s5000U／dlowmolecularweightheparin，andselectanother72casesoffetalgrowthrestrictionpregnancywomenthecorrespondingperiodwhoreceivedbasictreatmentasacontrolgroup．ResultsAftertreatment，meanuterineheightincrementandincrementsoffetalfemurlength，headcircumference，abdominalcircumferenceweres

6、ignificantlyhigherinexperimentalgroupthanthecontrolgroup；gestationalageofexperimentalgroupwas(38~3)weeks，thecontrolgroupwas(37~3)weeks；birthweightforex—perimentalgroupwas(2750~378)g，controlgroupwas(2240：1330)g；placentalweightofexperimentalgroupwas(490±110)g，whilethecontrolgroupwas(4

7、15~100)g；theincidenceofcomplicationsinexperimentalgroupwassignificantlylowerthanincontrolgroup．TheseitemsallhadasignificantlydifferencefP<0．05)．ConclusionDoctor—patientcommu—nicationshouldbestrengthenduringthecourseoftreatment，closelyobservationofpatients’performanceduringthetreatme

8、nt，whetherornotoccu